SynopsisSurgical slush units are medical instruments that are utilized during a surgery to prepare and maintain the slush used in keeping the organ stable, and to minimize tissue damage. A surgical slush unit maintains the surrounding temperature and prevents it from .....
SynopsisThe global Continuous Blood Glucose Monitoring Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. According to our research, the global mar.....
Synopsis The global Medical Radiation Shielding Products market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The Global Info Research report includes an .....
SynopsisThe global Semaglutide Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The Global Info Research report includes an overview of the development of the .....
SynopsisSkin booster refers to a cosmetic treatment that involves injecting hyaluronic acid or other skin-boosting substances into the skin to hydrate, rejuvenate, and improve skin texture and appearance. The global Skin Booster market was valued at US$ million .....
SynopsisIntranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical .....
SynopsisLenalidomide, sold under the trade name Revlimid among others, is a medication used to treat multiple myeloma (MM) and myelodysplastic syndromes (MDS). For MM it is used after at least one other treatment and generally together with dexamethasone. In Chi.....
SynopsisA Full-Service Contract Development and Manufacturing Organization (CDMO) is a company that provides comprehensive services across the entire drug development and manufacturing lifecycle, from early-stage development to commercial-scale production. These organ.....
SynopsisThe global Personalized Medicine for Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 202.....
SynopsisCD160 ELISA Kit is an experimental tool used to measure the concentration of CD160 protein in a sample. The global CD160 ELISA Kit market was valued at US$ 10 million in 2023 and is anticipated to reach US$ 16 million by 2030, witnessing a CAGR of 6.9% d.....
